(Q53387747)

13 May 2018

title

Development of a probucol-releasing antithrombogenic drug eluting stent. (English)

1 reference

13 May 2018

author name string

Kumar Vedantham

1

1 reference

13 May 2018

Somali Chaterji

2

1 reference

13 May 2018

Sung Won Kim

3

1 reference

13 May 2018

Kinam Park

4

1 reference

13 May 2018

publication date

14 February 2012

1 reference

13 May 2018

Journal of Biomedical Materials Research Part B

published in

1 reference

13 May 2018

volume

100

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

1068-1077

1 reference

13 May 2018

Drug-eluting stent restenosis the pattern predicts the outcome.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

New frontiers in cardiology: drug-eluting stents: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Drug-eluting stents: cost versus clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Vascular responses to drug eluting stents: importance of delayed healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

The excel stent: a good DES, but can we really stop clopidogrel after 6 months?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

In vitro and in vivo performance of a dual drug-eluting stent (DDES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Understanding the role of endothelial progenitor cells in percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Dietary and pharmacological antioxidants in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Probucol promotes functional reendothelialization in balloon-injured rabbit aortas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Role of endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Use of solubility parameters of drug and vehicle to predict flux through skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Miscibility/stability considerations in binary solid dispersion systems composed of functional excipients towards the design of multi-component amorphous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJBM.B.32672

21 January 2018

Identifiers

DOI

10.1002/JBM.B.32672

1 reference

13 May 2018

1 reference

13 May 2018